152 related articles for article (PubMed ID: 3844975)
1. Further studies on the differences in cytotoxicity of human peripheral blood monocytes and bronchoalveolar macrophages for cultured human lung cells.
Swinburne S; Moore M; Cole P
Cancer Immunol Immunother; 1985; 19(1):62-7. PubMed ID: 3844975
[TBL] [Abstract][Full Text] [Related]
2. Human peripheral blood monocyte and bronchoalveolar macrophage cytotoxicity for cultured human lung tumor cells.
Swinburne S; Cole P
J Reticuloendothel Soc; 1982 Nov; 32(5):371-85. PubMed ID: 6761437
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity on tumour cells of human mononuclear phagocytes: defective tumoricidal capacity of alveolar macrophages.
Bordignon C; Avallone R; Peri G; Polentarutti N; Mangioni C; Mantovani A
Clin Exp Immunol; 1980 Aug; 41(2):336-42. PubMed ID: 6160006
[TBL] [Abstract][Full Text] [Related]
4. Bronchoalveolar macrophage CD14 expression: shift between membrane-associated and soluble pools.
Hasday JD; Dubin W; Mongovin S; Goldblum SE; Swoveland P; Leturcq DJ; Moriarty AM; Bleecker ER; Martin TR
Am J Physiol; 1997 May; 272(5 Pt 1):L925-33. PubMed ID: 9176258
[TBL] [Abstract][Full Text] [Related]
5. Macrophage antitumor activity in vitro. Comparative analysis of cytolytic, cytostatic, and cytotoxic activities of mouse macrophages and human monocytes.
Soldateschi D; Censini S; de Gori V; Antoni G; Tagliabue A; Boraschi D
Immunobiology; 1984 May; 166(3):251-62. PubMed ID: 6376332
[TBL] [Abstract][Full Text] [Related]
6. Human bronchoalveolar macrophage cytotoxicity for cultured human lung-tumour cells.
Swinburne S; Moore M; Cole P
Br J Cancer; 1982 Oct; 46(4):625-34. PubMed ID: 7138768
[TBL] [Abstract][Full Text] [Related]
7. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
8. Natural cytotoxicity on tumour cells of human macrophages obtained from diverse anatomical sites.
Mantovani A; Bar Shavit Z; Peri G; Polentarutti N; Bordignon C; Sessa C; Mangioni C
Clin Exp Immunol; 1980 Mar; 39(3):776-84. PubMed ID: 6155233
[TBL] [Abstract][Full Text] [Related]
9. Antitumour potential of pleural cavity macrophages in lung cancer patients without malignant effusion.
Kimura S; Sone S; Takahashi K; Uyama T; Ogura T; Monden Y
Br J Cancer; 1989 Apr; 59(4):535-9. PubMed ID: 2785397
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients.
Wright SC; Jewett A; Mitsuyasu R; Bonavida B
J Immunol; 1988 Jul; 141(1):99-104. PubMed ID: 3132506
[TBL] [Abstract][Full Text] [Related]
11. Bronchoalveolar lavage and the immunology of primary lung cancer.
Olsen GN; Gangemi JD
Chest; 1985 May; 87(5):677-83. PubMed ID: 3886317
[TBL] [Abstract][Full Text] [Related]
12. Defective cytostatic activity of pulmonary alveolar macrophages in primary lung cancer.
McDonald CF; Atkins RC
Chest; 1990 Oct; 98(4):881-5. PubMed ID: 2119952
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cytotoxic and microbicidal function of bronchoalveolar and peritoneal macrophages.
Ryning FW; Krahenbuhl JL; Remington JS
Immunology; 1981 Apr; 42(4):513-9. PubMed ID: 7239556
[TBL] [Abstract][Full Text] [Related]
14. Bovine mononuclear phagocytic cells: identification by monoclonal antibodies and analysis of functional properties.
Ellis JA; Morrison WI; Goddeeris BM; Emery DL
Vet Immunol Immunopathol; 1987 Dec; 17(1-4):125-34. PubMed ID: 2963429
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity on tumor cells of peripheral blood monocytes and tumor-associated macrophages in patients with ascites ovarian tumors.
Mantovani A; Polentarutti N; Peri G; Shavit ZB; Vecchi A; Bolis G; Mangioni C
J Natl Cancer Inst; 1980 Jun; 64(6):1307-15. PubMed ID: 6246299
[TBL] [Abstract][Full Text] [Related]
16. Killing of alveolar macrophages and of monocytes that have responded to granulocyte-macrophage colony-stimulating factor by human lymphokine-activated killer cells.
Sone S; Inamura N; Singh SM; Okubo A; Yanagawa H; Nakanishi M; Ogura T
Jpn J Cancer Res; 1989 Jul; 80(7):662-9. PubMed ID: 2507489
[TBL] [Abstract][Full Text] [Related]
17. Dissociation between cytostatic and cytolytic activity of human monocytes towards K-562 cells.
Eggen BM; Lamvik JO
Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):261-4. PubMed ID: 6516853
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin.
Kornbluth RS; Edgington TS
J Immunol; 1986 Oct; 137(8):2585-91. PubMed ID: 3760568
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of natural killer activity by human bronchoalveolar macrophages.
Bordignon C; Villa F; Allavena P; Introna M; Biondi A; Avallone R; Mantovani A
J Immunol; 1982 Aug; 129(2):587-91. PubMed ID: 6177770
[TBL] [Abstract][Full Text] [Related]
20. Cytostatic activity of peripheral blood monocytes against bronchogenic carcinoma cells in patients with lung cancer.
Yanagawa E; Yasumoto K; Manabe H; Nagano N; Hirota N; Ohta M; Hattori T; Nomoto K; Azuma I; Yamamura Y
Gan; 1979 Aug; 70(4):533-9. PubMed ID: 229054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
